2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Prospective Measurement of Plasma Neutrophil Gelatinase-Associated Lipoprotein in Living Kidney Donors

Y. Yoon,¹ K. Choi,² D. Joo,³ K. Huh,³ M. Kim,³ S. Kim,³ Y. Kim,³ S. Yang,² W. Han.¹
Prospective Study of a Steroid Free, Low Dose Tacrolimus and Everolimus Combination Regimen in Kidney Transplant

A. Shetty,¹ J. Leventhal,¹ O. Traitanon,¹ A. Alvarado,¹ V. Mas,² J. Mathew,¹ E. Tantisattamo,¹ L. Gallon.¹
Prospective, 6 Month, Open Label, Conversion Study from Mycophenolate Mofetyl to Mycophenolic Acid Evaluating the Severity of Gastro-Intestinal Symptoms and Mycophenolic Acid Urinary Metabolite as a Surrogate Marker of Plasmatic Area Under the Curve

D. Tran,¹ A. Boucher,¹ L. Senécal,¹ V. Pichette,¹ F. Leblond,² S. Collette.¹
Prospects of Differentiating T-Cell Mediated Rejection (TCMR) from BK Virus Nephropathy (BKVN) Using Next Generation Sequencing (NGS) of the T-Cell Receptor (TCR)

G. Zeng, Y. Huang, P. Randhawa.
Proteasome Activation During Renal Cold Storage and Transplantation: A Novel Pathway for Mitochondrial Destruction?

N. Parajuli, L. MacMillan-Crow.
Proteasome Inhibition by Bortezomib Prevents Early Graft Failure After Pancreatic Islet Transplantation

H. Ono,¹ Y. Asahi,¹ T. Yoshida,¹ Y. Koshizuka,¹ M. Watanabe,¹ U. Tomaru,² S. Emoto,¹ M. Fukai,³ A. Taketomi,¹ S. Todo,⁴ K. Yamashita.³
Protecting Older Patients from Dialysis: The Survival Benefit of Preemptive Transplant With High KDPI Allografts

C. Jay,¹ K. Washburn,¹ P. Dean,² R. Helmick,² M. Stegall.²
Proteinuria as Non-Invasive Marker for Renal Allograft Histology and Survival: A Population-Based Study

M. Naesens, E. Lerut, M.-P. Emonds, D. Kuypers.
Proteomic Study Identified a Distinct Panel of Protein Expression in the ATP-Competitive MTOR Kinase Inhibitor Conditioned Dendritic Cells Compared to Rapamycin

T. Ma,¹ Y. Pei,¹ Y. Han,² R. Tao.¹
Protocol Donor Specific Antibody Monitoring After Kidney Transplantation: What Is the Utility?

C. Staino, N. Pilch, O. Moussa, K. Boyle, J. Casale, K. Covert, J. Fleming, D. Taber, H. Meadows, C. Mardis, K. Chavin, S. Nadig, J. McGillicuddy, C. Bratton, T. Srinivas, P. Baliga.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z